INSTITUTION'S PROFILE
Zuyderland Medical Center, Sittard-Geleen, The Netherlands.
Publications (5)
Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study.
Journal: PLOS digital health
Publication date:
Journal: PLOS digital health
Publication Year:
Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network.
Journal: Journal of neurology, neurosurgery, and psychiatry
Publication date: 2022
Journal: Journal of neurology, neurosurgery, and psychiatry
Publication Year: 2022
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
Journal: JAMA neurology
Publication date: 2023
Journal: JAMA neurology
Publication Year: 2023
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies.
Journal: Journal of neurology
Publication date: 2024
Journal: Journal of neurology
Publication Year: 2024
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.
Journal: Journal of medical economics
Publication date: 2023
Journal: Journal of medical economics
Publication Year: 2023